| Patients who complieted cycles (% of treated patients) | |||
| Cycle 1 | 20/20 (100%) | ||
| Cycle 2 | 20/20 (100%) | ||
| Cycle 3 | 20/20 (100%) | ||
| Cycle 4 | 18/20 (90%) | ||
| CDDP | Vinorelbine | ||
| Planned cumulative dose (mg/m2) | 400 | 200 | |
| Actuarial cumulative dose (mg/m2) | |||
| Median | 390 (290 - 400) | 200 (150 - 200) | |
| Average | 378.3 (290 - 400) | 190.5 (150 - 200) | |
| Dose intensity [mg/(m2 week)] | |||
| Median | 24.7 (23.1 - 25) | 12.5 (10 - 12.5) | |
| Average | 24.2 (23.1 - 25) | 12.2 (10 - 12.5) | |
| Relative dose intensity (%) | |||
| Median | 97.5% | 100% | |
| Average | 94.6% | 95.3% | |